Malaysia’s Pharmaniaga to make pneumococcal vaccine, will seek JAKIM halal certification
Malaysia’s largest listed pharmaceutical company Pharmaniaga will manufacture the pneumococcal vaccine on license from the Serum Institute of India.
The vaccine protects against pneumococcal disease, that is any type of illness caused by the streptococcus pneumoniae bacteria. The bacterial infection causes illnesses such as pneumonia and meningitis. The vaccine is primarily given to children.
Pharmaniaga said in a statement that the agreement with India’s Serum will allow its subsidiary Pharmaniaga Lifescience (PLS) to purchase the vaccine and manufacture using the technology licensed by Serum for filling and finishing in the form of pre-filled syringes.
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
